Mark T Drayson

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

G. Morgan, M. Drayson, F. Davies, 2003, The New England journal of medicine.

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Gordon Cook, David A Cairns, G. Morgan, 2014, Nature Communications.

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

Gordon Cook, David A Cairns, Matthew Scales, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HL60 cells halted in G1 or S phase differentiate normally.

Roger Bird, M. Drayson, K. Toellner, 2002, Experimental cell research.